Michael R. Megna
CHIEF ACCOUNTING OFFICER
SEC EDGAR ↗CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals International, plc, filing insider transactions between 2025-05-07 and 2026-04-09.
Total Purchases
—
0 transactions
Total Sales
$4.1M
7 transactions
Companies Traded
1
7 total filings
Active Since
2025-05-07
Last: 2026-04-09
Other Reporting Insiders at Kiniksa Pharmaceuticals International, plc
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-04-09 | KNSA | Sale | 6,625 | $46.69 | $309K | 27.4K | SEC ↗ |
| 2025-10-20 | KNSA | Sale | 37.3K | $38.72 | $1.4M | 40.3K | SEC ↗ |
| 2025-10-20 | KNSA | Sale | 13.2K | $39.31 | $520K | 27.0K |
Director & CHAIRMAN & CEO
Michael R. Megna (Kiniksa Pharmaceuticals International, plc) Insider Trades | Tormere